Bayer, A. C., Sanmarco, L. M., Pellerin, A., Masi, G., Plasencia, A., Anderson, J. M., Nowak, R. J., Damato, V., Massacesi, L., Pham, M. C., Khani-Habibabadi, F., Vital, H., Higginson-Scott, N., Otipoby, K. L., Xing, Y., Mascanfroni, I. D., O’Connor, K. C. (2025). Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2505984122